Abstract 4744

Malnutrition is a major problem in children with cancer. All conventional modalities of anti cancer therapy interfere with normal nutrition. In this study we retrospectively analyzed 331 children of Acute Lymphoblastic Leukaemia (ALL) being intensively treated by National cancer Institute protocol (MCP 841) during period from August, 2000 to December, 2010 in a tertiary cancer institute of the country. Our aim was to determine the nutritional status of children with ALL at diagnosis and to study the influence of nutrition on complete remission, disease free survival (DFS) and toxicity of chemotherapy. The variables studied were height for age, weight for age and serum albumin levels. The height for age and the weight for age were taken as normal if they were between 3rd and 97th percentile curve of the growth chart as recommended by the Indian Council of Medical Research (ICMR). The albumin level was considered normal if the value was equal to or more than 3 gm%. It was seen that 16.9% children were low weight for age and 10.3% were of low height for age at diagnosis. Low weight for age (p value <0.01) and low albumin (p-value <0.005) were significant in DFS.

We conclude that malnutrition is having much impact on prognosis of ALL in developing countries like ours. The major nutrition indicators are height for age, weight for age and serum albumin. The patients with malnutrition have less DFS duration, more chances of relapse and more toxicity during therapy as compared to well nourished children.

Table 1:

Nutritional status of 331 children

VariablesNormalLow
Weight for age 275 (83.08%) 56 (16.91%) 
Height for Age 297 (89.73%) 34 (10.3%) 
Total Protein 274 (82.78%) 57 (17.22%) 
Serum Albumin 301 (90.94%) 30 (9.06%) 
VariablesNormalLow
Weight for age 275 (83.08%) 56 (16.91%) 
Height for Age 297 (89.73%) 34 (10.3%) 
Total Protein 274 (82.78%) 57 (17.22%) 
Serum Albumin 301 (90.94%) 30 (9.06%) 
Table 2:

Effect of Nutritional variables on remission of ALL

VariableTotalRemissionNon ResponderInduction DeathTotal failure of Inductionp-value
Normal Weight for age 275 260 (94.54%) 4 (1.45%) 11 (4%) 15 (5.45%)  
Low Weight for Age 56 51 (91.1%) 5 (8.9%) 5 (8.9%) 0.236 
Normal Height for Age 297 283 (95.23%) 4 (1.35%) 10 (3.37%) 14 (4.7%)  
Low Height for Age 34 28 (82.35%) 1 (2.94%) 5 (14.7%) 6 (17.6%)  
Normal Albumin 301 287 (95.35%) 2 (0.66%) 12 (4%) 14 (4.6%)  
Low Albumin 30 24 (80%) 2 (6.7%) 4 (13.3%) 6 (20%)  
VariableTotalRemissionNon ResponderInduction DeathTotal failure of Inductionp-value
Normal Weight for age 275 260 (94.54%) 4 (1.45%) 11 (4%) 15 (5.45%)  
Low Weight for Age 56 51 (91.1%) 5 (8.9%) 5 (8.9%) 0.236 
Normal Height for Age 297 283 (95.23%) 4 (1.35%) 10 (3.37%) 14 (4.7%)  
Low Height for Age 34 28 (82.35%) 1 (2.94%) 5 (14.7%) 6 (17.6%)  
Normal Albumin 301 287 (95.35%) 2 (0.66%) 12 (4%) 14 (4.6%)  
Low Albumin 30 24 (80%) 2 (6.7%) 4 (13.3%) 6 (20%)  
Table 3:

Effect of Nutritional variables on Disease Free Survival

VariableTotalDFS (%)Relapse Death (%)Death due to Other Causes (%)Total Deathp-value
Normal Weight for age 275 198 (72%) 59 (21.45%) 18 (6.54%) 77 (28%)  
Low Weight for Age 56 19 (33.9%) 25 (44.6%) 12 (21.4%) 37 (66%) .001 
Normal Height for Age 297 213 (71.7%) 68 (22.9%) 16 (5.4%) 84 (28.3%)  
Low Height for Age 34 4 (11.8%) 20 (58.8%) 10 (29.4%) 30 (88.2%) 0.0001 
Normal Albumin 301 212 (70.4%) 62 (20.6%) 27 (8.97%) 89 (29.6%)  
Low Albumin 30 5 (16.7%) 13 (43.33%) 12 (40%) 25 (83.3%) 0.0001 
VariableTotalDFS (%)Relapse Death (%)Death due to Other Causes (%)Total Deathp-value
Normal Weight for age 275 198 (72%) 59 (21.45%) 18 (6.54%) 77 (28%)  
Low Weight for Age 56 19 (33.9%) 25 (44.6%) 12 (21.4%) 37 (66%) .001 
Normal Height for Age 297 213 (71.7%) 68 (22.9%) 16 (5.4%) 84 (28.3%)  
Low Height for Age 34 4 (11.8%) 20 (58.8%) 10 (29.4%) 30 (88.2%) 0.0001 
Normal Albumin 301 212 (70.4%) 62 (20.6%) 27 (8.97%) 89 (29.6%)  
Low Albumin 30 5 (16.7%) 13 (43.33%) 12 (40%) 25 (83.3%) 0.0001 
Table 4:

Effect of Nutritional variables on Toxicity Profile

VariableMyeloLiverGINeuroMetabolicPancreatitisTotal
Normal Weight for age (275) 45 (16.36%) 15 (5.45%) 1 (0.36%) 13 (4.72%) 2 (0.72%) 2 (0.72%) 55 (20%) 
Low Weight for Age (56) 21 (37.5%) 9 (16.07%) 3 (5.36%) 5 (8.93%)  2 (5.36%) 24 (42.8%) 
Normal Height for Age (297) 50 (16.8%) 17 (5.72%) 2 (0.67%) 14 (4.71%) 2 (0.67%) 2 (0.67%) 61 (20.8%) 
Low Height for Age (34) 16 (47%) 7 (20.5%) 2 (5.8%) 4 (11.6%)  2 (5.8%) 18 (52.9%) 
Normal Albumin (301) 12 (3.98%) 3 (0.99%) 2 (0.66%)  1 (0.33%) 64 (21.3%) 
Low Albumin (30) 24 (66.67%) 21 (58.33%) 4 (11.1%) 16 (44.4%) 2 (5.55%) 3 (8.3%) 15 (50%) 
VariableMyeloLiverGINeuroMetabolicPancreatitisTotal
Normal Weight for age (275) 45 (16.36%) 15 (5.45%) 1 (0.36%) 13 (4.72%) 2 (0.72%) 2 (0.72%) 55 (20%) 
Low Weight for Age (56) 21 (37.5%) 9 (16.07%) 3 (5.36%) 5 (8.93%)  2 (5.36%) 24 (42.8%) 
Normal Height for Age (297) 50 (16.8%) 17 (5.72%) 2 (0.67%) 14 (4.71%) 2 (0.67%) 2 (0.67%) 61 (20.8%) 
Low Height for Age (34) 16 (47%) 7 (20.5%) 2 (5.8%) 4 (11.6%)  2 (5.8%) 18 (52.9%) 
Normal Albumin (301) 12 (3.98%) 3 (0.99%) 2 (0.66%)  1 (0.33%) 64 (21.3%) 
Low Albumin (30) 24 (66.67%) 21 (58.33%) 4 (11.1%) 16 (44.4%) 2 (5.55%) 3 (8.3%) 15 (50%) 
Table 5:

Comparison of the effect of Nutritional variables in Remission vs Relapse Group with Other Studies

VariablesYu LC et al (1994)Present Study (2011)
Remission GroupRelapseRemission GroupRelapse
Weight % 106.4 ± 29.9 109.1 ± 19.3 23.96 ± 13.44 21.1 ± 10.1 
Height % 99.3 ± 4.9 104.9 ± 16.1 121.17 ± 27.02 117.85 ± 22.8 
Protein Mean   6.65 ± 0.88 6.38 ± 1.12 
Albumin Mean 4.23 ± 0.3 3.59 ± 0.58 4.01 ± 0.73 3.63 ± 0.93 
VariablesYu LC et al (1994)Present Study (2011)
Remission GroupRelapseRemission GroupRelapse
Weight % 106.4 ± 29.9 109.1 ± 19.3 23.96 ± 13.44 21.1 ± 10.1 
Height % 99.3 ± 4.9 104.9 ± 16.1 121.17 ± 27.02 117.85 ± 22.8 
Protein Mean   6.65 ± 0.88 6.38 ± 1.12 
Albumin Mean 4.23 ± 0.3 3.59 ± 0.58 4.01 ± 0.73 3.63 ± 0.93 

Disclosures:

No relevant conflicts of interest to declare.

Author notes

*

Asterisk with author names denotes non-ASH members.

Sign in via your Institution